CareDx: AlloSure Expanded Indications

CareDx's donor-derived cell-free DNA (dd-cfDNA)-based AlloSure transplant health assay is now commercially available for pediatric heart transplant patients of all ages, as well as patients who have received a simultaneous pancreas-kidney (SPK) transplant. Both indications were approved by the New York State Clinical Laboratory Evaluation Program.